AI4CMR vs Imbio PHA (4.0.0)

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AI4CMR

by AI4MedImaging Medical Solutions

Imbio PHA (4.0.0)

by Imbio

AI Verdict

While both AI solutions assist in cardiac assessment, their direct comparability is limited by their distinct imaging modalities and specific analytical focus. AI4CMR is designed for comprehensive cardiac MRI interpretation, providing automated segmentation and flow quantification. In contrast, Imbio PHA (4.0.0) specializes in analyzing CT pulmonary angiogram (CTPA) scans to measure cardiac structures for assessing right ventricular dilation, pulmonary embolism, and hypertension.

Choose AI4CMR if…

Choose AI4CMR if your primary need is automated, comprehensive cardiac MRI interpretation for detailed cardiac function analysis. This cloud-native solution excels at rapid, zero-click segmentation of ventricles for volume quantification and classification of wall motion, streamlining high-volume MRI workflows.

View AI4CMR →

Choose Imbio PHA (4.0.0) if…

Choose Imbio PHA (4.0.0) if you require automated analysis of CT pulmonary angiogram (CTPA) scans to assess right ventricular dilation and aid in the diagnosis and risk stratification of pulmonary embolism and hypertension. It specializes in rapidly measuring cardiac and pulmonary artery diameters and calculating critical ratios like RV/LV and PA/Ao.

View Imbio PHA (4.0.0) →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	AI4CMR	Imbio PHA (4.0.0)
Pricing	Paid	Contact for pricing
Deployment	Cloud-native; cloud-hosted service; integrates with existing PACS, RIS, and EHR systems; lightweight gateway for local connectivity	Cloud, Enterprise (on-premise), or via partners
FDA Status	1 AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

AI4CMR

AI4CMR explicitly highlights 'Zero-click AI capabilities' and a 'Cloud-native' architecture, suggesting a highly automated and low-friction user experience with minimal setup. While Imbio PHA also emphasizes rapid, automated assessment, AI4CMR's specific phrasing implies a slightly more streamlined and hands-off operational model.

Clinical Value

AI4CMR

Both tools are FDA-cleared and provide significant clinical value within their respective imaging modalities. AI4CMR offers a broader range of automated quantitative analyses for Cardiac MRI, including segmentation, volume quantification, wall motion classification, and flow quantification. Imbio PHA focuses on specific measurements from CTPA for pulmonary embolism and hypertension, which is valuable but more specialized in scope compared to AI4CMR's comprehensive cardiac function analysis.

Pricing & Value

AI4CMR

AI4CMR offers a transparent 'Cost-effective SaaS Pay Per Use model' with a 'pay-per-exam model,' 'no upfront hardware,' and 'no hidden fees.' This clear and predictable pricing structure provides a distinct advantage in assessing value compared to Imbio PHA, which requires users to 'contact for pricing.'

Enterprise Readiness

Imbio PHA (4.0.0)

Imbio PHA offers greater deployment flexibility, supporting Cloud, Enterprise (on-premise), or partner deployments, which can be critical for larger organizations with diverse IT infrastructures and data governance needs. Additionally, Imbio's HIPAA compliance is explicitly 'third-party certified by compliancy group,' providing an extra layer of assurance for enterprise adoption.

Innovation

AI4CMR

Both tools leverage AI for automated medical image analysis. However, AI4CMR's 'Zero-click AI capabilities' and its ability to perform 'Automated analytical flow quantification' for Cardiac MRI represent a high degree of automation and advanced quantitative analysis within its domain, indicating a slightly more innovative approach to user interaction and comprehensive data extraction.

Support & Docs

Tie

Neither the provided structured facts nor readily available web search results offer sufficient specific details regarding the quality, availability, or channels of support and documentation for either AI4CMR or Imbio PHA. While Imbio mentions 'comprehensive support,' a direct comparison is not possible with the current information.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	AI4CMR	Imbio PHA (4.0.0)
Name	AI4CMR	Imbio PHA (4.0.0)
Company	AI4MedImaging Medical Solutions	Imbio
Primary Application Focus	Automates Cardiac MRI interpretation, streamlining workflows and providing rapid, accurate cardiac function analysis.	Automatically measures cardiac structures from CT pulmonary angiogram (CTPA) scans to assess potential right ventricular dilation and aid in the diagnosis and risk stratification of pulmonary embolism and hypertension.
Key Cardiac Structures Analyzed	Automatic segmentation of left and right ventricles for volume quantification	Automated measurement of right and left ventricle diameters; Automated measurement of main pulmonary artery and aorta diameters; Calculates RV/LV and PA/Ao ratios
Output/Integration	Real-time processing and delivery of structured, editable results; Interoperability with existing systems via DICOM, HL7, and FHIR	Generates annotated DICOM images; Provides summary reports in PDF format; Integrates with native DICOM tools and workflows
Automation Level	Zero-click AI capabilities for automated analysis; Automated analytical flow quantification	Rapid, fully-automated assessment (typically in minutes)

Videos

Demos, reviews, and walkthroughs featuring AI4CMR and Imbio PHA (4.0.0).

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What imaging modalities do these tools support?

AI4CMR is specifically designed for the interpretation of Cardiac MRI (CMR) images, including cine and 2D phase-encoded images. In contrast, Imbio PHA (4.0.0) processes CT pulmonary angiogram (CTPA) scans to measure cardiac structures.

What specific cardiac analyses do these tools provide?

AI4CMR automates cardiac MRI interpretation, focusing on automatic segmentation of left and right ventricles for volume quantification, classification of normal and suspicious wall motion cases, and analytical flow quantification. Imbio PHA (4.0.0) automatically measures cardiac structures from CTPA scans, including right and left ventricle diameters, main pulmonary artery and aorta diameters, and calculates RV/LV and PA/Ao ratios.

How do these tools integrate with existing clinical workflows and what are their output formats?

AI4CMR integrates with existing systems via DICOM, HL7, and FHIR protocols, delivering real-time, structured, and editable results directly to a browser. Imbio PHA (4.0.0) generates annotated DICOM images and provides summary reports in PDF format, integrating with native DICOM tools and workflows.